Acute lung injury and its more severe form acute respiratory distress syndrome (ARDS) are characterized by diff use impairment of alveolocapillary membrane in the settings of diff erent predisposing conditions such as sepsis, trauma and shock. Many intrahospital exposures, including aspiration, delayed resuscitation, high tidal volume mechanical ventilation and non critical use of transfusions may contribute or worsen ARDS. Th erapy is targeted to treatment of predisposing condition, life supportive measures and prevention of nosocomial complications. Rigorous adherence to lungprotective mechanical ventilation is critical to prevent ventilator induced lung injury and decrease mortality. Although survival of ARDS patients has improved in the last decades ARDS mortality rates are still high and survivors encounter signifi cant physical and psychological impairments.
Introduction
More than  years ago Ashbaugh et al. fi rst described acute respiratory distress syndrome (ARDS), a life threatening condition in patients with precipitating factors and mortality that ranged from  to . In recent years many basic and clinical studies have improved our understanding of ARDS but the clinical impact has been limited to advances in supportive treatment. ARDS affects   people in US every year, and is associated with  deaths, . millions hospital days and mortality of approximately  (,) .
History
In  Ashbaugh et al described  patients with acute respiratory failure, oxygen refractory cyanosis and diff use alveolar infi ltrates on chest X ray () . Th e syndrome was first named adult respiratory distress syndrome () , but soon after it was noted in children it was renamed to acute respiratory distress syndrome. Due to lack of clear definition in  an attempt was made to quantify respiratory impairment in terms of lung injury score (LIS) based on four parameters: radiographic changes, level of hypoxia (PaO/ FiO), lung compliance and positive end expiratory pressure (PEEP). Factors causing direct and indirect lung injury were defined, and the role of multiorgan failure (MOF) was emphasized in terms of prognosis () . The lack of specificity and inability to differentiate between ARDS and heart failure resulted in current definition by American-European Consensus Conference Committee in  (Table ) () .
Defi nition
Acute respiratory distress syndrome is a syndrome of acute respiratory failure with radiological feature of acute pulmonary edema in the absence of clinical evidence of left heart failure as a principal explanation of pulmonary edema. The condition is characterized by abrupt injury in alveolocapillary membrane resulting in alveolar flooding, inflammation and change in surfactant properties that cause severe impairment of oxygenation and respiratory failure requiring mechanical ventilation () . Th e defi nition takes into account the degree of respiratory impairment and distinguishes acute lung injury (ALI) and a more severe form acute respiratory distress syndrome. Although early recognition of these patients facilitates enrollment into clinical trials, previous studies found no correlation between PaO/FiO and survival (, ) . Th e majority of patients who present with ALI progress to ARDS within fi rst three days () . Arterial oxygen saturation measured by pulse oximetry is useful in estimating level of respiratory impairment in both pediatric patients and adults (SaO/ FiO of  and  correspond to PaO/FiO=, SaO/FiO= and  corresponds to PaO/ FiO= in adults and children, respectively) (, ) .
Etiology
The diagnosis of ALI is usually made in the ICU but the biological process begins much earlier. ALI/ARDS is rarely present at the time of hospital admission and usually develops in first hours to days after hospital admission in patients with predisposing conditions that can cause direct (pneumonia, aspiration, imAmerican-European Consensus Conference Committee Acute onset Bilateral chest radiographic infi ltrates consistent with edema PaO2/FIO2 <300 for ALI and PaO2/FIO2 <200 for ARDS Th e absence of clinical evidence of left atrial hypertension as the principal explanation for pulmonary edema; PCWP≤18mmHg; () . Risk factors associated with the development of ALI are summarized in Table  .
Pathophysiology
Acute lung injury is characterized by damage and increased vascular permeability of alveolocapillary membrane that result in protein rich pulmonary edema (increased permeability edema as opposed to hydrostatic edema in cardiogenic shock) () . Injury to alveolocapillary membrane can be physical (increased pulmonary pressure), chemical or due to an activation of immune response. Th ese aff ect both alveolar epithelium and capillary endothelium. Alveolar epithelium consists mainly () of alveolar epithelial cells type I that are responsible for gas exchange and prevent extravasation of fl uid into alveoli. Cubic, alveolar epithelial cells type II are less prone to injury and have a role in reabsorption of the fl uid and surfactant production. Proliferation of alveolar cells type II and their diff erentiation to alveolar epithelial cells type I allows healing of alveolocapillary membrane () . Injury of alveolar epithelial cells type II causes dysregulation in surfactant production and results in severe derangements of respiratory mechanics and decrease in pulmonary compliance. Endothelial cells edema and widening of intercellular gaps causes increase in vascular permeability ('capillary leak syndrome') () . Both inadequate and hyperimmune response can cause injury of the alveolocapillary membrane. Dysregulation of infl ammation in immune response is the common cause of acute lung injury () . After initial stimuli activate macrophages to secrete tumor necrosis factor TNF α and IL- neutrophils migrate into intraalveolar space. Activated neutrophils, endothelial and epithelial cells induce a cascade of cytokines that amplify immune response. Products of neutrophils such as oxygen radicals and proteases can result in damage of the membrane ('collateral damage') () . Epithelial cells are also found to have an active role in infl ammation. In pulmonary infections activated macrophages directly (IL-, TNF-α) or indirectly (T-cells) stimulate nuclear factor kβ (NFkβ) pathway of epithelial cells that consequently leads to increased production of chemokines, colony stimulating factors and adhesion molecules. Experimental studies have shown that inhibition of inflammatory molecules may have a protective role in ARDS () . Some but not all studies indicated correlation between increased plasma or bronchoalveolar TNF-a and development of or mortality in ARDS (, , ) . Recent genomic studies of cytokines and their receptors have shown that polymorphism in the genes for TNF-α is associated with increased mortality of ARDS, as well as ARDS susceptibility in some subgroups of patients according to the site of injury () . Damage to epithelial and endothelial cells and production of inflammatory cytokines can lead to increased expression of tissue factor and stimulation of inhibitors of plasminogen activators. In addition levels of activated protein C (APC), antithrombin (AT) and tissue factor pathway inhibitor (TFPI) are found to be lower in sepsis due to decreased production and increased degradation () thus leading to increased fi brin production and microvascular thrombosis early in the course of ARDS () .
Histology
Pathohistological changes in ARDS correspond to diffuse alveolar damage-DAD. Acute, exudative phase develops within first week and is characterized by interstitial and intraalveolar edema, capillary congestion, neutrophilic infiltrate, macrophages, erythrocytes and presence of hyaline membranes-eosinophilic structures which consist of cellular debris and proteins (albumin, fi brinogen and immunoglobulins). Elements of vascular microthrombosis are also present. Late, proliferative phase develops in first two weeks after insult. Proliferation of cuboid cells, fibroblasts, and myofibroblasts are seen with rare cellular infiltrate and interstitial deposition of collagen () . DAD results in loss of the integrity of the alveolar-capillary barrier, exudation of protein-rich fl uid across the barrier, pulmonary edema, and hypoxemia. Although described in  by Katzeinstein () and considered to be a pathological substrate of ALI/ARDS presence of DAD was never included as one of the criteria in previous defi nitions since lung tissue is rarely available for pathological diagnosis. Furthermore, in patients with positive clinical criteria histological conformation of DAD is found in only about  on post mortem analysis (, ) . Clinical and pathohistological defi nition correlates better in patients with extrapulmonary ARDS () .
Diagnosis
Diagnosis of ALI is largely based on interpretation of chest radiograph that is consistent with pulmonary edema. Interpretation of chest X ray in critically ill may be diffi cult due to diff erences in quality, infl uence of mechanical ventilation as well as subjectivity of the interpreter. The interobserver agreement in applying radiographic criterion of ACCP defi nition was found to be moderate (kappa .) (). Cardiothoracic ratio and vascular pedicular width could be useful in diff erentiating cardiogenic from non-cardiogenic pulmonary edema () . CT fi ndings in ARDS correspond to ground glass opacity and zone dependent heterogeneous consolidations () . Patients with extrapulmonary causes of ARDS present more often with symmetric evenly distributed ground glass opacification in contrast to ARDS associated with pulmonary risk factors where the infi ltrates tend to be asymmetric with a mix of dorsocaudal consolidation and ground glass opacification () . In recent years there has been an increasing use of ultrasound techniques in the ICU which are valuable in assessing cardiac function as well as presence of lung edema by lung ultrasonography ('comet tail sign') () . Preserved systolic function does not rule out cardiogenic edema since diastolic dysfunction (E/E'>) is the common cause of cardiogenic edema. Echocardiography also allows evaluation of pulmonary hypertension and functional status of the right ventricle. Excessive stretching of the ventricles induces secretion of Brain natriuretic peptide-BNP by myocytes. Values of  pg/mL are highly specifi c for diagnosis of non cardiogenic pulmonary edema while values of  pg/ dl and higher are suggestive of heart failure ( Table . ). Right heart failure which is often observed in ARDS can cause elevated values of BNP (-pg/dl) () . In diff erential diagnosis there are conditions that can present as ARDS but require specifi c treatment (Table  . ). In the case of unclear etiology of ARDS surgical biopsy may have a crucial role in establishing diagnosis and initiation of appropriate therapy, especially in immunocompromised patients (table .) () . In previous studies, open lung biopsy in ARDS cases of unclear etiology led to alteration of treatment in majority of cases (-) and was not associated with increased morbidity (-).
Treatment is focused on identification and management of predisposing condition such as adequate infection source control and supportive therapy. With the exception of low tidal volume strategy no other medical intervention or pharmacology treatment has been proven to reduce mortality in ARDS patients.
Mechanical ventilation
Lung protective ventilation using low tidal volumes ml/kg predicted body weight according to US National Institutes of Health Network for the Acute Respiratory Distress Syndrome (NIH ARDS Network) has led to a reduction of overall mortality from . to . in ARDS patients () . Years of experimental studies indicated that using traditional tidal volumes of -ml/kg can cause or worsen lung injury by direct mechanical stress, overdistension of healthy part of the lungs (volutrauma) (-) , cyclic opening and closing of alveoli (atelectrauma) (,) and increasing production of proinfl ammatory cytokines (biotrauma) (- sure (PEEP) opens atelectatic alveoli, decreases fraction of intrapulmonary shunt and improves oxygenation. On the other hand PEEP may cause distension of healthy part of the lungs and increase dead space fraction, decrease ventricular preload and cause hypotension. Th ere is no evidence in diff erence in survival using high and low PEEP values () . Use of low tidal volumes is shown to decrease concentration of infl ammation markers and frequency of extrapulmonary organ failures compared to traditional ventilation modes () . In case of inadequate oxygenation unconventional mechanical ventilation may be indicated. High frequency oscillation HFO uses rapid delivery ( to  breaths in minutes, Fr -HZ) of low tidal volumes (often below the values of anatomical dead-space). Th e concept of HFO is similar to low tidal volume ventilation. Experimental studies have shown lower level of lung injury and infl ammation in HFO compared to conventional ventilation (, ) . Small volumes prevent overdistension of alveoli while high mean pressure in airways prevents its collapse. Downsides of using HFO are risk of pneumothorax and hemodynamic instability due to decreased stroke volume. Preliminary studies failed to show benefi t of survival in patients who were ventilated with HFO that could be due to a late initiation of HFO. Future studies should be focused on identifying patients who could benefit from unconventional mechanical ventilation and timing of initiation of HFO in these patients () . In the cases of severe refractory hypoxemia extracorporeal membrane oxygenation (ECMO) could be initiated. The benefit of ECMO remained to be confirmed in controlled clinical trials (Conventional ventilation or ECMO for Severe Adult Respiratory Failure -CESAR TRIAL) () . Lung recruitment and prone position can improve oxygenation but effect is often transient, and there is no evidence of improved survival () .
Noninvasive mechanical ventilation
Non invasive mechanical ventilation (NIV) may be used in early stages of ALI in patients without multiorgan failure and in whom there is no expectation of prolonged mechanical ventilation. Presence of shock and acidosis are associated with failure of NIV. All noninvasively ventilated ALI patients should be closely monitored to prevent potential delay in intubation (, ) .
Fluid management
Due to an increased vascular permeability reduced fl uid intake is benefi cial to a gas exchange. On the other hand reduction of circulatory volume can impair tissue oxygenation. Conservative fluid strategy reduces days on mechanical ventilation and ICU length of stay but does not affect overall mortality or development of acute renal failure. Similarly, use of pulmonary arterial catheter was not found to be superior to central venous catheter () . After initial fl uid resuscitation fl uid administration should be closely monitored and CVP should be maintained at  mmHg if shock is not present. Negative cumulative fl uid balance at day  is associated with reduced mortality in acute lung injury () .
Corticosteroids
Inflammatory changes in ALI as well as possible hyperimmune response and pathohistological changes in late ARDS give rationale for the use of corticosteroids in both early and late stages of ARDS. In the eighties high dose of corticosteroids were used for the treatment of ARDS but after reports of increased mortality related to their use, corticosteroids were used more cautiously. Corticosteroids have an indication in following clinical conditions that may present as ARDS: vasculitis (diff use alveolar hemorrhage), acute eosinophilic pneumonia, acute interstitial pneumonia and acute bronchiolitis obliterans with organizing pneumonia. SARS experience has shown positive eff ect of corticosteroids on some infectious forms of ARDS. There is evidence that in early ARDS (inside first  h) use of corticosteroids may decrease days of mechanical ventilation, ICU length of stay and hospital mortality but this data needs to be confirmed in larger clinical trials () . National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network study did not show diff erence in survival of patients with persistent ARDS (at least seven days) who did and did not receive corticosteroids, although there were evidence of improved gas exchange, respiratory compliance and ventilator free days () . For those enrolled at least  days after the onset of ARDS the mortality rates in corticosteroid group were higher. Based on these results current guidelines do not recommend routine administration of corticosteroids in ARDS. Although previously associated with critical illness neuromyopathy and increased infection rates two recent meta-analysis found no relationship between use of corticosteroids and infection, neuromyopathy, or any major complications in ARDS patients (, ) .
Pulmonary vasodilators
Use of semi-selective (nitric oxide, prostacyclin, prostaglandin E) and non-selective (nitroprus-side, hydralazine) vasodilators can improve oxygenation and reduce pulmonary hypertension in severe refractory forms of hypoxia by reducing pulmonary vascular resistance and improving perfusion of well ventilated parts of lungs. In spite of obvious physiological effects clinical studies failed to confi rm its eff ect on reducing overall mortality rates () .
Surfactant replacement
Although in ARDS metabolism of surfactant is severely impaired use of surfactant did not improve survival in adults. Th ere is evidence that some subgroups of ARDS patients such as those with pneumonia and aspiration could benefi t from treatment with surfactant () . Possible additional therapeutic targets include use of antioxidants, β adrenergic receptor agonists, ACE inhibitors and nutritional modifications as well as use of GM-CSF and activated protein C (, ) . Other supportive measures include adequate nutrition, stress ulcer, DVT and decubital prophylaxis. Recent data show that intensive insulin therapy reduces the duration of mechanical ventilation, duration of ICU stay and -day mortality in ICU patients but there are no exclusive data on subpopulation of ALI patients. Th ere is evidence that intensive insulin therapy reduces the incidence of critical illness polyneuro-and/or myopathy () .
Prognosis
Severe impairment of alveolar epithelia and failure to improve in fi rst week are associated with adverse outcome () . Older patients with sepsis, liver diseases and MOF carry worse prognosis () . Although severe impairment of pulmonary function is a hallmark of ARDS only two pulmonary features, oxygenation index and increased dead space fraction ventilation are shown to be of predictive value () . Th e main cause of death is withdrawal of treatment due to irreversible MOF () and low quality of life in older patients () and patients with signifi cant comorbidities. About  of patients will be mechanically ventilated for more than a month () . In some patients acute phase may be complicated with fibrosing alveolitis and persisting hypoxemia, increased dead space ventilation and reduced compliance. First fi brotic changes may appear after - days () . Obliteration of pulmonary capillaries and refractory hypoxia can cause severe pulmonary hypertension with right heart failure. In those who recover radiologic changes withdraw gradually and pulmonary function test recovers completely, sometimes with mild restriction, obstruction or decreased diff usion capacity that are usually asymptomatic () . Histological resolution in ARDS survivors is not well known. Prospective studies have indicated that ARDS survivors have impaired quality of life at one year follow up. Main problems that ARDS survivors are facing are weight loss, deconditioning, cognitive and psychological problems as well as neuromuscular weakness ().
Conclusion
Although survival of ARDS patients has been signifi cantly improved in the last decades ARDS mortality rates are still high and survivors encounter signifi cant physical and psychological impairments. Early treatment of predisposing conditions and the prevention of "second hit" in-hospital exposures are critical for prevention and treatment of this important complication of critical illness. Since ARDS patients represent etiologically and pathophysiologically a heterogeneous group of patients future studies should be focused on better defi ning subgroups of patients that could benefi t from specifi c target therapies. 
